Dr. Leona Blustein, program director of the industry residency program and assistant professor of clinical pharmacy, tells PharmaVocie people can benefit from having a mentor at any point in their careers and mentors can provide guidance to people who haven’t yet entered the workforce.
Read more: http://www.pharmavoice.com/content/digitaledition.html?pg=30
"One of the elements of unfairness of these prescription benefit programs is that the same companies who design the programs own the mail-order pharmacies to which patients are directed," said Daniel Hussar, a professor at the Philadelphia College of Pharmacy and author of The Pharmacist Activist newsletter.
Read more: http://www.northjersey.com/news/162499516_New_assault_on_drugstores.html
The Associated Press reached out on Saturday to see if we had an expert who could talk about the medication mix up in New Jersey. Dan Hussar was readily available to speak with the AP. The AP story he was quoted in resulted in 165 stories around the nation that our clipping service grabbed as well as nearly 600 on hits on Google.
"Fortunately, it's very unlikely that this specific drug would cause any serious or adverse effects when used for only a short periods of time," said Daniel Hussar, a professor with the Philadelphia College of Pharmacy at the University of the Sciences.
Read more: http://www.nbcphiladelphia.com/news/local/NJ-CVS-Gives-Breast-Cancer-Pills-To-Kids-141302873.html
Pharmaceutical Press chose Philadelphia and the Science Center due to its proximity to the pharmaceutical industry and area universities including new customer, the University of the Sciences -- a Science Center shareholder.
Karen J. Tietze listed among associate editors.
The '2nd Annual State of Clinical Development Cost Conference' hosted by USciences and sponsored by TTC will highlight a variety of detailed research throughout this two day event. Are you interested in learning new and fascinating facts about site start-up costs in clinical trial agreements?
The Seeding Drug Discovery Award of up to $4.7 million is to aid the translational research being carried out by Paul M. Lieberman, a professor at Wistar. Lieberman leads the Center for Chemical Biology and Translational Medicine at Wistar, a partnership between Wistar and University of the Sciences in Philadelphia.
The '2nd Annual State of Clinical Development Cost Conference' hosted by USciences and sponsored by TTC will highlight a variety of detailed research throughout this two day event. Are you curious how much CROs are actually used? Or how much CROs are involved in key clinical trial activity areas? Curious how the use of CRO's affect study completion times? These questions will be explored and answered during the conference.
Dr. Dan Hussar conducted a series of interviews on a new survey that reveals that not all winter-time sore throats are a result of the common cold or worse yet, the flu virus.
The ‘2nd Annual State of Clinical Development Cost Conference’ hosted by USciences and sponsored by TTC will cover a variety of detailed pharmaceutical research throughout this two day event.
Read more: http://www.sunherald.com/2011/12/08/3620971/increase-your-knowledge-on-global.html
